Ribosome-inactivating proteins potent poisons and molecular tools

Virulence

Volumn 4, Issue 8, 2013, Pages

  Walsh, Matthew J ^a   Dodd, Jennifer E ^a   Hautbergue, Guillaume M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Sarcin; Abrin; Analytical and therapeutic applications; Biological weapon; BLF1; BPSL1549; Eukaryotic protein synthesis inhibition; Ricin; Saporin; Shiga toxins

Indexed keywords

ABRIN; BACTERIAL TOXIN; BURKHOLDERIA LETHAL FACTOR 1; GLOBOTRIAOSYLCERAMIDE; GLYCOSIDASE; INITIATION FACTOR; RIBONUCLEASE A; RIBONUCLEASE T1; RIBOSOME INACTIVATING PROTEIN; RIBOTOXIN; RICIN; RNA 28S; SAPORIN; SHIGA TOXIN; UNCLASSIFIED DRUG; VEROTOXIN; BLF1 TOXIN, BURKHOLDERIA PSEUDOMALLEI; POISON; PROTEIN SYNTHESIS INHIBITOR;

BIOLOGICAL WARFARE; CLINICAL RESEARCH; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; ISOLATION AND PURIFICATION; LETHAL GENE; MOLECULAR MECHANICS; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; REVIEW; RNA TRANSLATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; ANALYTICAL AND THERAPEUTIC APPLICATIONS; BLF1; BPSL1549; EUKARYOTIC PROTEIN SYNTHESIS INHIBITION; METABOLISM; Α-SARCIN;

ABRIN; ANALYTICAL AND THERAPEUTIC APPLICATIONS; BIOLOGICAL WEAPON; BLF1; BPSL1549; EUKARYOTIC PROTEIN SYNTHESIS INHIBITION; RICIN; SAPORIN; SHIGA TOXINS; Α-SARCIN;

BACTERIAL TOXINS; HUMANS; POISONS; PROTEIN SYNTHESIS INHIBITORS; RIBOSOME INACTIVATING PROTEINS; RNA, RIBOSOMAL, 28S;

EID: 84888332415     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.26399     Document Type: Review

References (141)

1. Stirpe F, Battelli MG. Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci 2006; 63:1850-66; PMID:16799768; http://dx.doi.org/10.1007/s00018-006-6078-7
2. Barbieri L, Polito L, Bolognesi A, Ciani M, Pelosi E, Farini V, Jha AK, Sharma N, Vivanco JM, Chambery A, et al. Ribosome-inactivating proteins in edible plants and purification and characterization of a new ribosome-inactivating protein from Cucurbita moschata. Biochim Biophys Acta 2006; 1760:783-92; PMID:16564632; http://dx.doi.org/10.1016/j.bbagen.2006.01.002
3. Johannes L, Römer W. Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol 2010; 8:105-16; PMID:20023663
4. Puri M, Kaur I, Perugini MA, Gupta RC. Ribosome-inactivating proteins: current status and biomedical applications. Drug Discov Today 2012; 17:774-83; PMID:22484096; http://dx.doi.org/10.1016/j.drudis.2012.03.007
5. Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K. Shiga toxins. Toxicon 2012; 60:1085-107; PMID:22960449; http://dx.doi.org/10.1016/j.toxicon.2012.07.016
6. Stirpe F. Ribosome-inactivating proteins: from toxins to useful proteins. Toxicon 2013; 67:12-6; PMID:23462379; http://dx.doi.org/10.1016/j.toxicon.2013.02.005
7. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8:225-30; PMID:11897082; http://dx.doi.org/10.3201/eid0802.010164
8. Stirpe F. Ribosome-inactivating proteins. Toxicon 2004; 44:371-83; PMID:15302521; http://dx.doi.org/10.1016/j.toxicon.2004.05.004
9. Olsnes S, Pihl A. Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry 1973; 12:3121-6; PMID:4730499; http://dx.doi.org/10.1021/bi00740a028
10. Olsnes S, Pihl A. Isolation and properties of abrin: a toxic protein inhibiting protein synthesis. Evidence for different biological functions of its two constituent-peptide chains. Eur J Biochem 1973; 35:179-85; PMID:4123356; http://dx.doi.org/10.1111/j.1432-1033.1973.tb02823.x
11. Barbieri L, Ciani M, Girbés T, Liu W-Y, Van Damme EJM, Peumans WJ, Stirpe F. Enzymatic activity of toxic and non-toxic type 2 ribosomeinactivating proteins. FEBS Lett 2004; 563:219-22; PMID:15063752; http://dx.doi.org/10.1016/S0014-5793(04)00286-8
12. Montanaro L, Sperti S, Mattioli A, Testoni G, Stirpe F. Inhibition by ricin of protein synthesis in vitro. Inhibition of the binding of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 to ribosomes. Biochem J 1975; 146:127-31; PMID:167711
13. Stirpe F. On the action of ribosome-inactivating proteins: are plant ribosomes species-specific? Biochem J 1982; 202:279-80; PMID:7082314
14. Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 1987; 262:5908-12; PMID:3571242
15. Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987; 262:8128-30; PMID:3036799
16. Lacadena J, Alvarez-García E, Carreras-Sangrà N, Herrero-Galán E, Alegre-Cebollada J, GarcíaOrtega L, Oñaderra M, Gavilanes JG, Martínez del Pozo A. Fungal ribotoxins: molecular dissection of a family of natural killers. FEMS Microbiol Rev 2007; 31:212-37; PMID:17253975; http://dx.doi.org/10.1111/j.1574-6976.2006.00063.x
17. Cruz-Migoni A, Hautbergue GM, Artymiuk PJ, Baker PJ, Bokori-Brown M, Chang C-T, Dickman MJ, Essex-Lopresti A, Harding SV, Mahadi NM, et al. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science 2011; 334:821-4; PMID:22076380; http://dx.doi.org/10.1126/science.1211915
18. Hautbergue GM, Wilson SA. BLF1, the first Burkholderia pseudomallei toxin, connects inhibition of host protein synthesis with melioidosis. Biochem Soc Trans 2012; 40:842-5; PMID:22817745; http://dx.doi.org/10.1042/BST20120057
19. Olsnes S. The history of ricin, abrin and related toxins. Toxicon 2004; 44:361-70; PMID:15302520; http://dx.doi.org/10.1016/j.toxicon.2004.05.003
20. Audi J, Belson M, Patel M, Schier J, Osterloh J. Ricin poisoning: a comprehensive review. JAMA 2005; 294:2342-51; PMID:16278363; http://dx.doi.org/10.1001/jama.294.18.2342
21. Tahirov TH, Lu TH, Liaw YC, Chu SC, Lin JY. A new crystal form of abrin-a from the seeds of Abrus precatorius. J Mol Biol 1994; 235:1152-3; PMID:8289316; http://dx.doi.org/10.1006/jmbi.1994.1066
22. Weston SA, Tucker AD, Thatcher DR, Derbyshire DJ, Pauptit R A. X-ray structure of recombinant ricin A-chain at 1.8 A resolution. J Mol Biol 1994; 244:410-22; PMID:7990130; http://dx.doi.org/10.1006/jmbi.1994.1739
23. Lin JY, Chang YC, Huang LY, Tung TC. The cytotoxic effects of abrin and ricin on Ehrlich ascites tumor cells. Toxicon 1973; 11:379-81; PMID:4751114; http://dx.doi.org/10.1016/0041-0101(73)90037-8
24. Olsnes S, Pihl A. Ricin a potent inhibitor of protein synthesis. FEBS Lett 1972; 20:327-9; PMID:11946449; http://dx.doi.org/10.1016/0014-5793(72)80098-X
25. Montanaro L, Sperti S, Stirpe F. Inhibition by ricin of protein synthesis in vitro. Ribosomes as the target of the toxin. Biochem J 1973; 136:677-83; PMID:4780693
26. Ogasawara T, Sawasaki T, Morishita R, Ozawa A, Madin K, Endo Y. A new class of enzyme acting on damaged ribosomes: ribosomal RNA apurinic site specific lyase found in wheat germ. EMBO J 1999; 18:6522-31; PMID:10562564; http://dx.doi.org/10.1093/emboj/18.22.6522
27. Olsnes S, Fernandez-Puentes C, Carrasco L, Vazquez D. Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem 1975; 60:281-8; PMID:1204642; http://dx.doi.org/10.1111/j.1432-1033.1975.tb21001.x
28. Endo Y, Tsurugi K. The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem 1988; 263:8735-9; PMID:3288622
29. Peumans WJ, Hao Q, Van Damme EJ. Ribosomeinactivating proteins from plants: more than RNA N-glycosidases? FASEB J 2001; 15:1493-506; PMID:11427481; http://dx.doi.org/10.1096/fj.00-0751rev
30. Sandvig K, Grimmer S, Iversen TG, Rodal K, Torgersen ML, Nicoziani P, van Deurs B. Ricin transport into cells: studies of endocytosis and intracellular transport. Int J Med Microbiol 2000; 290:415-20; PMID:11111920; http://dx.doi.org/10.1016/S1438-4221(00)80055-7
31. Sandvig K, van Deurs B. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol Rev 1996; 76:949-66; PMID:8874490
32. van Deurs B, Tønnessen TI, Petersen OW, Sandvig K, Olsnes S. Routing of internalized ricin and ricin conjugates to the Golgi complex. J Cell Biol 1986; 102:37-47; PMID:3001103; http://dx.doi.org/10.1083/jcb.102.1.37
33. Sandvig K, Torgersen ML, Engedal N, Skotland T, Iversen T-G. Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine. FEBS Lett 2010; 584:2626-34; PMID:20385131; http://dx.doi.org/10.1016/j.febslet.2010.04.008
34. Sandvig K, van Deurs B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett 2002; 529:49-53; PMID:12354612; http://dx.doi.org/10.1016/S0014-5793(02)03182-4
35. Lord JM, Roberts LM. Toxin entry: retrograde transport through the secretory pathway. J Cell Biol 1998; 140:733-6; PMID:9472027; http://dx.doi.org/10.1083/jcb.140.4.733
36. Rapak A, Falnes PO, Olsnes S. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc Natl Acad Sci U S A 1997; 94:3783-8; PMID:9108055; http://dx.doi.org/10.1073/pnas.94.8.3783
37. Roberts LM, Smith DC. Ricin: the endoplasmic reticulum connection. Toxicon 2004; 44:469-72; PMID:15450920; http://dx.doi.org/10.1016/j.toxicon.2004.07.002
38. Spooner RA, Watson PD, Marsden CJ, Smith DC, Moore KAH, Cook JP, Lord JM, Roberts LM. Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem J 2004; 383:285-93; PMID:15225124; http://dx.doi.org/10.1042/BJ20040742
39. Lord JM, Spooner RA. Ricin trafficking in plant and mammalian cells. Toxins (Basel) 2011; 3:787-801; PMID:22069740; http://dx.doi.org/10.3390/toxins3070787
40. Griffiths GD, Leek MD, Gee DJ. The toxic plant proteins ricin and abrin induce apoptotic changes in mammalian lymphoid tissues and intestine. J Pathol 1987; 151:221-9; PMID:3572616; http://dx.doi.org/10.1002/path.1711510310
41. Narayanan S, Surendranath K, Bora N, Surolia A, Karande AA. Ribosome inactivating proteins and apoptosis. FEBS Lett 2005; 579:1324-31; PMID:15733836; http://dx.doi.org/10.1016/j.febslet.2005.01.038
42. Brigotti M, Alfieri R, Sestili P, Bonelli M, Petronini PG, Guidarelli A, Barbieri L, Stirpe F, Sperti S. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells. FASEB J 2002; 16:365-72; PMID:11874985; http://dx.doi.org/10.1096/fj.01-0521com
43. Narayanan S, Surolia A, Karande AA. Ribosomeinactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells. Biochem J 2004; 377:233-40; PMID:13129434; http://dx.doi.org/10.1042/BJ20030797
44. Sestili P, Alfieri R, Carnicelli D, Martinelli C, Barbieri L, Stirpe F, Bonelli M, Petronini PG, Brigotti M. Shiga toxin 1 and ricin inhibit the repair of H2O2-induced DNA single strand breaks in cultured mammalian cells. DNA Repair (Amst) 2005; 4:271-7; PMID:15590335; http://dx.doi.org/10.1016/j.dnarep.2004.09.007
45. Hasegawa N, Kimura Y, Oda T, Komatsu N, Muramatsu T. Isolated ricin B-chain-mediated apoptosis in U937 cells. Biosci Biotechnol Biochem 2000; 64:1422-9; PMID:10945259; http://dx.doi.org/10.1271/bbb.64.1422
46. Trofa AF, Ueno-Olsen H, Oiwa R, Yoshikawa M. Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus. Clin Infect Dis 1999; 29:1303-6; PMID:10524979; http://dx.doi.org/10.1086/313437
47. Keusch GT, Grady GF, Mata LJ, McIver J. The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest 1972; 51:1212-8; PMID:4560429; http://dx.doi.org/10.1172/JCI106915
48. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18:775-9; PMID:338490
49. O'Brien AD, LaVeck GD, Thompson MR, Formal SB. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis 1982; 146:763-9; PMID:6754826; http://dx.doi.org/10.1093/infdis/146.6.763
50. O'Brien AD, Newland JW, Miller SF, Holmes RK, Smith HW, Formal SB. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 1984; 226:694-6; PMID:6387911; http://dx.doi.org/10.1126/science.6387911
51. O'Brien AO, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1983; 1:702; PMID:6132054; http://dx.doi.org/10.1016/S0140-6736(83)91987-6
52. Unkmeir A, Schmidt H. Structural analysis of phageborne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun 2000; 68:4856-64; PMID:10948097; http://dx.doi.org/10.1128/IAI.68.9.4856-4864.2000
53. Herold S, Karch H, Schmidt H. Shiga toxin-encoding bacteriophages--genomes in motion. Int J Med Microbiol 2004; 294:115-21; PMID:15493821; http://dx.doi.org/10.1016/j.ijmm.2004.06.023
54. Johansen BK, Wasteson Y, Granum PE, Brynestad S. Mosaic structure of Shiga-toxin-2-encoding phages isolated from Escherichia coli O157:H7 indicates frequent gene exchange between lambdoid phage genomes. Microbiology 2001; 147:1929-36; PMID:11429469
55. Gamage SD, Strasser JE, Chalk CL, Weiss AA. Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun 2003; 71:3107-15; PMID:12761088; http://dx.doi.org/10.1128/IAI.71.6.3107-3115.2003
56. Cornick NA, Helgerson AF, Mai V, Ritchie JM, Acheson DWK. In vivo transduction of an Stxencoding phage in ruminants. Appl Environ Microbiol 2006; 72:5086-8; PMID:16820511; http://dx.doi.org/10.1128/AEM.00157-06
57. Stein PE, Boodhoo A, Tyrrell GJ, Brunton JL, Read RJ. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 1992; 355:748-50; PMID:1741063; http://dx.doi.org/10.1038/355748a0
58. Fraser ME, Chernaia MM, Kozlov YV, James MN. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat Struct Biol 1994; 1:59-64; PMID:7656009; http://dx.doi.org/10.1038/nsb0194-59
59. Donohue-Rolfe A, Keusch GT. Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock. Infect Immun 1983; 39:270-4; PMID:6295958
60. De Grandis S, Ginsberg J, Toone M, Climie S, Friesen J, Brunton JL. Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J Bacteriol 1987; 169:4313-9; PMID:3040689
61. Strockbine NA, Jackson MP, Sung LM, Holmes RK, O'Brien AD. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol 1988; 170:1116-22; PMID:2830229
62. Jackson MP, Newland JW, Holmes RK, O'Brien AD. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb Pathog 1987; 2:147-53; PMID:3333796; http://dx.doi.org/10.1016/0882-4010(87)90106-9
63. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988; 171:45-50; PMID:3276522; http://dx.doi.org/10.1111/j.1432-1033.1988.tb13756.x
64. Saxena SK, O'Brien AD, Ackerman EJ. Shiga toxin, Shiga-like toxin II variant, and ricin are all singlesite RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem 1989; 264:596-601; PMID:2642481
65. Thompson MR, Steinberg MS, Gemski P, Formal SB, Doctor BP. Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun 1976; 71:783-8; PMID:786292; http://dx.doi.org/10.1016/0006-291X(76)90899-8
66. Brown JE, Rothman SW, Doctor BP. Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin. Infect Immun 1980; 29:98-107; PMID:6156915
67. Lindberg AA, Brown JE, Strömberg N, Westling Ryd M, Schultz JE, Karlsson KA. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 1987; 262:1779-85; PMID:3543013
68. Ling H, Boodhoo A, Hazes B, Cummings MD, Armstrong GD, Brunton JL, Read RJ. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 1998; 37:1777-88; PMID:9485303; http://dx.doi.org/10.1021/bi971806n
69. Waddell T, Cohen A, Lingwood CA. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A 1990; 87:7898-901; PMID:2236008; http://dx.doi.org/10.1073/pnas.87.20.7898
70. Okuda T, Tokuda N, Numata S-I, Ito M, Ohta M, Kawamura K, Wiels J, Urano T, Tajima O, Furukawa K, et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem 2006; 281:10230-5; PMID:16476743; http://dx.doi.org/10.1074/jbc.M600057200
71. DeGrandis S, Law H, Brunton J, Gyles C, Lingwood CA. Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem 1989; 264:12520-5; PMID:2663859
72. Donohue-Rolfe A, Acheson DW, Kane AV, Keusch GT. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun 1989; 57:3888-93; PMID:2807552
73. Bonifacino JS, Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol 2006; 7:568-79; PMID:16936697; http://dx.doi.org/10.1038/nrm1985
74. Johannes L, Popoff V. Tracing the retrograde route in protein trafficking. Cell 2008; 135:1175-87; PMID:19109890; http://dx.doi.org/10.1016/j.cell.2008.12.009
75. Chiron MF, Fryling CM, FitzGerald DJ. Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. J Biol Chem 1994; 269:18167-76; PMID:8027078
76. Garred O, van Deurs B, Sandvig K. Furin-induced cleavage and activation of Shiga toxin. J Biol Chem 1995; 270:10817-21; PMID:7738018; http://dx.doi.org/10.1074/jbc.270.18.10817
77. Sandvig K, Dubinina E, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B. Protein toxins: mode of action and cell entry. Biochem Soc Trans 1992; 20:724-7; PMID:1487049
78. Garred O, Dubinina E, Polesskaya A, Olsnes S, Kozlov J, Sandvig K. Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells. J Biol Chem 1997; 272:11414-9; PMID:9111051; http://dx.doi.org/10.1074/jbc.272.17.11414
79. LaPointe P, Wei X, Gariépy J. A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen. J Biol Chem 2005; 280:23310-8; PMID:15817449; http://dx.doi.org/10.1074/jbc.M414193200
80. Yu M, Haslam DB. Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect Immun 2005; 73:2524-32; PMID:15784599; http://dx.doi.org/10.1128/IAI.73.4.2524-2532.2005
81. Tam PJ, Lingwood CA. Membrane cytosolic translocation of verotoxin A1 subunit in target cells. Microbiology 2007; 153:2700-10; PMID:17660434; http://dx.doi.org/10.1099/mic.0.2007/006858-0
82. Tesh VL. Induction of apoptosis by Shiga toxins. Future Microbiol 2010; 5:431-53; PMID:20210553; http://dx.doi.org/10.2217/fmb.10.4
83. Tesh VL. The induction of apoptosis by Shiga toxins and ricin. Curr Top Microbiol Immunol 2012; 357:137-78; PMID:22130961; http://dx.doi.org/10.1007/82_2011_155
84. Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL, Magun BE. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol 1997; 17:3373-81; PMID:9154836
85. Eisenhauer PB, Chaturvedi P, Fine RE, Ritchie AJ, Pober JS, Cleary TG, Newburg DS. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 2001; 69:1889-94; PMID:11179369; http://dx.doi.org/10.1128/IAI.69.3.1889-1894.2001
86. Lee S-Y, Lee M-S, Cherla RP, Tesh VL. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell Microbiol 2008; 10:770-80; PMID:18005243; http://dx.doi.org/10.1111/j.1462-5822.2007.01083.x
87. Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T, Wiels J. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 1993; 53:5314-9; PMID:8221667
88. Taga S, Carlier K, Mishal Z, Capoulade C, Mangeney M, Lécluse Y, Coulaud D, Tétaud C, Pritchard LL, Tursz T, et al. Intracellular signaling events in CD77mediated apoptosis of Burkitt's lymphoma cells. Blood 1997; 90:2757-67; PMID:9326243
89. Barbieri L, Stirpe F. Ribosome-inactivating proteins from plants: properties and possible uses. Cancer Surv 1982; 1:489-520
90. Ishizaki T, Megumi C, Komai F, Masuda K, Oosawa K. Accumulation of a 31-kDa glycoprotein in association with the expression of embryogenic potential by spinach callus in culture. Physiol Plant 2002; 114:109-15; PMID:11982941; http://dx.doi.org/10.1034/j.1399-3054.2002.1140115.x
91. Ferreras JM, Barbieri L, Girbés T, Battelli MG, Rojo MA, Arias FJ, Rocher MA, Soriano F, Mendéz E, Stirpe F. Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae). Biochim Biophys Acta 1993; 1216:31-42; PMID:8218413; http://dx.doi.org/10.1016/0167-4781(93)90034-B
92. Savino C, Federici L, Ippoliti R, Lendaro E, Tsernoglou D. The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome. FEBS Lett 2000; 470:239-43; PMID:10745075; http://dx.doi.org/10.1016/S0014-5793(00)01325-9
93. Barbieri L, Battelli MG, Stirpe F. Ribosomeinactivating proteins from plants. Biochim Biophys Acta 1993; 1154:237-82; PMID:8280743; http://dx.doi.org/10.1016/0304-4157(93)90002-6
94. Bagga S, Seth D, Batra JK. The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities. J Biol Chem 2003; 278:4813-20; PMID:12466280; http://dx.doi.org/10.1074/jbc.M207389200
95. Santanché S, Bellelli A, Brunori M. The unusual stability of saporin, a candidate for the synthesis of immunotoxins. Biochem Biophys Res Commun 1997; 234:129-32; PMID:9168975; http://dx.doi.org/10.1006/bbrc.1997.6597
96. Cavallaro U, Nykjaer A, Nielsen M, Soria MR. Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins. Eur J Biochem 1995; 232:165-71; PMID:7556146; http://dx.doi.org/10.1111/j.1432-1033.1995.tb20795.x
97. Weng A, Bachran C, Fuchs H, Melzig MF. Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein. Chem Biol Interact 2008; 176:204-11; PMID:18775419; http://dx.doi.org/10.1016/j.cbi.2008.08.004
98. Vago R, Marsden CJ, Lord JM, Ippoliti R, Flavell DJ, Flavell S-U, Ceriotti A, Fabbrini MS. Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells. FEBS J 2005; 272:4983-95; PMID:16176271; http://dx.doi.org/10.1111/j.1742-4658.2005.04908.x
99. Olson BH, Goerner GL. ALPHA SARCIN, A NEW ANTITUMOR AGENT. I. ISOLATION, PURIFICATION, CHEMICAL COMPOSITION, AND THE IDENTITY OF A NEW AMINO ACID. Appl Microbiol 1965; 13:314-21; PMID:14325268
100. Endo Y, Wool IG. Mechanism of Action of AlphaSarcin and Eukaryotic Ribosome Structure. Fed Proc 1982; 41:1456
101. Martínez-Ruiz A, Kao R, Davies J, Martínez del Pozo A. Ribotoxins are a more widespread group of proteins within the filamentous fungi than previously believed. Toxicon 1999; 37:1549-63; PMID:10482390; http://dx.doi.org/10.1016/S0041-0101(99)00103-8
102. Endo Y, Wool IG. The site of action of alpha-sarcin on eukaryotic ribosomes. The sequence at the alphasarcin cleavage site in 28 S ribosomal ribonucleic acid. J Biol Chem 1982; 257:9054-60; PMID:7047533
103. Glück A, Endo Y, Wool IG. The ribosomal RNA identity elements for ricin and for alpha-sarcin: mutations in the putative CG pair that closes a GAGA tetraloop. Nucleic Acids Res 1994; 22:321-4; PMID:8127668; http://dx.doi.org/10.1093/nar/22.3.321
104. Lacadena J, Martínez del Pozo A, Martínez-Ruiz A, Pérez-Cañadillas JM, Bruix M, Mancheño JM, Oñaderra M, Gavilanes JG. Role of histidine-50, glutamic acid-96, and histidine-137 in the ribonucleolytic mechanism of the ribotoxin alpha-sarcin. Proteins 1999; 37:474-84; PMID:10591106; http://dx.doi.org/10.1002/(SICI)1097-0134(19991115)37:3474::AIDPROT143.0.CO;2-N
105. Masip M, Lacadena J, Mancheño JM, Oñaderra M, Martínez-Ruiz A, Martínez del Pozo A, Gavilanes JG. Arginine 121 is a crucial residue for the specific cytotoxic activity of the ribotoxin alpha-sarcin. Eur J Biochem 2001; 268:6190-6; PMID:11733014; http://dx.doi.org/10.1046/j.0014-2956.2001.02566.x
106. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006; 4:272-82; PMID:16541135; http://dx.doi.org/10.1038/nrmicro1385
107. Whitmore A, Krishnaswami CS. An account of the discovery of a hitherto undescribed infective disease occurring among the population of Rangoon. Ind Med Gaz 1912; 47:262-7
108. Holden MTG, Titball RW, Peacock SJ, CerdeñoTárraga AM, Atkins T, Crossman LC, Pitt T, Churcher C, Mungall K, Bentley SD, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 2004; 101:14240-5; PMID:15377794; http://dx.doi.org/10.1073/pnas.0403302101
109. Hautbergue G. [Characterisation of Burkholderia pseudomallei Lethal Factor 1 (BLF1). A breakthrough against melioidosis]. Med Sci (Paris) 2012; 28:262-4; PMID:22480647; http://dx.doi.org/10.1051/medsci/2012283011
110. Wongtrakoongate P, Mongkoldhumrongkul N, Chaijan S, Kamchonwongpaisan S, Tungpradabkul S. Comparative proteomic profiles and the potential markers between Burkholderia pseudomallei and Burkholderia thailandensis. Mol Cell Probes 2007; 21:81-91; PMID:17030112; http://dx.doi.org/10.1016/j.mcp.2006.08.006
111. Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC, Sonenberg N. mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol 2011; 12:235-45; PMID:21427765; http://dx.doi.org/10.1038/nrm3083
112. Linder P, Jankowsky E. From unwinding to clamping the DEAD box RNA helicase family. Nat Rev Mol Cell Biol 2011; 12:505-16; PMID:21779027; http://dx.doi.org/10.1038/nrm3154
113. Andreou AZ, Klostermeier D. The DEAD-box helicase eIF4A: paradigm or the odd one out? RNA Biol 2013; 10:19-32; PMID:22995829; http://dx.doi.org/10.4161/rna.21966
114. Marintchev A. Roles of helicases in translation initiation: a mechanistic view. Biochim Biophys Acta 2013; 1829:799-809; PMID:23337854; http://dx.doi.org/10.1016/j.bbagrm.2013.01.005
115. Augerson WS. A review of the scientific literature as it pertains to Gulf War illnesses. Volume 5: Chemical and Biological Warfare Agents. Rand Corporation 2000; ISBN 0-8330-2680-1.
116. Gupta RC. Handbook of toxicology of chemical warfare agents. Boston: Academic Press 2009; ISBN 978-0-12-374484-5.
117. Schep LJ, Temple WA, Butt GA, Beasley MD. Ricin as a weapon of mass terror--separating fact from fiction. Environ Int 2009; 35:1267-71; PMID:19767104; http://dx.doi.org/10.1016/j.envint.2009.08.004
118. Griffiths GD. Understanding ricin from a defensive viewpoint. Toxins (Basel) 2011; 3:1373-92; PMID:22174975; http://dx.doi.org/10.3390/toxins3111373
119. Vitetta ES, Smallshaw JE, Coleman E, Jafri H, Foster C, Munford R, Schindler J. A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci U S A 2006; 103:2268-73; PMID:16461456; http://dx.doi.org/10.1073/pnas.0510893103
120. Stone R. Infectious disease. Racing to defuse a bacterial time bomb. Science 2007; 317:1022-4; PMID:17717162; http://dx.doi.org/10.1126/science.317.5841.1022
121. Aldhous P. Tropical medicine: melioidosis? Never heard of it Nature 2005; 434:692-3; PMID:15815599; http://dx.doi.org/10.1038/434692a
122. Sprague LD, Neubauer H. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public Health 2004; 51:305-20; PMID:15525357; http://dx.doi.org/10.1111/j.1439-0450.2004.00797.x
123. Lee YH, Chen Y, Ouyang X, Gan Y-H. Identification of tomato plant as a novel host model for Burkholderia pseudomallei. BMC Microbiol 2010; 10:28-38; PMID:20109238; http://dx.doi.org/10.1186/1471-2180-10-28
124. Patel N, Conejero L, De Reynal M, Easton A, Bancroft GJ, Titball RW. Development of vaccines against burkholderia pseudomallei. Front Microbiol 2011; 2:198; PMID:21991263; http://dx.doi.org/10.3389/fmicb.2011.00198
125. Neubauer H, Meyer H, Finke EJ. Human glanders. Rev Int Serv Sante Forces Armees 1997; 70:258-65
126. Nierman WC, DeShazer D, Kim HS, Tettelin H, Nelson KE, Feldblyum T, Ulrich RL, Ronning CM, Brinkac LM, Daugherty SC, et al. Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci U S A 2004; 101:14246-51; PMID:15377793; http://dx.doi.org/10.1073/pnas.0403306101
127. Sharrer GT. The great glanders epizootic, 1861-1866: a Civil War legacy. Agric Hist 1995; 69:79-97; PMID:11639801
128. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM Jr. Biological warfare. A historical perspective. JAMA 1997; 278:412-7; PMID:9244333; http://dx.doi.org/10.1001/jama.1997.03550050074036
129. Wheelis M. First shots fired in biological warfare. Nature 1998; 395:213; PMID:9751039; http://dx.doi.org/10.1038/26089
130. Fong IW, Alibek K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York: Springer; 2005. p. 99-145. (Book 4).
131. Blagden SP, Willis AE. The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol 2011; 8:280-91; PMID:21364523; http://dx.doi.org/10.1038/nrclinonc.2011.16
132. Malina A, Cencic R, Pelletier J. Targeting translation dependence in cancer. Oncotarget 2011; 2:76-88; PMID:21378410
133. Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Blättler WA. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use. Cancer Res 1991; 51:6236-42; PMID:1718599
134. Schnell R, Borchmann P, Staak JO, Schindler J, Ghetie V, Vitetta ES, Engert A. Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Ann Oncol 2003; 14:729-36; PMID:12702527; http://dx.doi.org/10.1093/annonc/mdg209
135. Kuroda K, Liu H, Kim S, Guo M, Navarro V, Bander NH. Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity. Prostate 2010; 70:1286-94; PMID:20623630
136. Allen JW, Mantyh PW, Horais K, Tozier N, Rogers SD, Ghilardi JR, Cizkova D, Grafe MR, Richter P, Lappi DA, et al. Safety evaluation of intrathecal substance P-saporin, a targeted neurotoxin, in dogs. Toxicol Sci 2006; 91:286-98; PMID:16500924; http://dx.doi.org/10.1093/toxsci/kfj143
137. Li M, Chen Y, Liu Z, Shen F, Bian X, Meng Y. Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol. Acta Biochim Biophys Sin (Shanghai) 2009; 41:792-9; PMID:19727528; http://dx.doi.org/10.1093/abbs/gmp068
138. Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 1994; 14:5986-95; PMID:7523630
139. Ho M-C, Sturm MB, Almo SC, Schramm VL. Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins. Proc Natl Acad Sci U S A 2009; 106:20276-81; PMID:19920175; http://dx.doi.org/10.1073/pnas.0911606106
140. Fraser ME, Cherney MM, Marcato P, Mulvey GL, Armstrong GD, James MNG. Binding of adenine to Stx2, the protein toxin from Escherichia coli O157:H7. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006; 62:627-30; PMID:16820678; http://dx.doi.org/10.1107/S1744309106021968
141. Mlsna D, Monzingo AF, Katzin BJ, Ernst S, Robertus JD. Structure of recombinant ricin A chain at 2.3 A. Protein Sci 1993; 2:429-35; PMID:8453380; http://dx.doi.org/10.1002/pro.5560020315